Conversations on 
Twitter :
-
What turnaround? Fitch dashes hopes that the drug-approval trend will see an uptick.
Conversation started by @JohnCFierce -
Tough issues surround discussions of cancer drugs' cost-effectiveness.
@RyanMFierce participated in this discussion
@FierceBiotech: Models shed light on cocaine-curbing enzymes. More | Follow @FierceBiotech
@JohnCFierce: Wall Street oddsmakers betting heavily against Lilly's solanezumab. News | Follow @JohnCFierce
@RyanMFierce: Illumina is poised to grab more bioinformatics dollars with its cloud computing product, eventual app store. Release | Follow @RyanMFierce
> GSK ($GSK) chief Andrew Witty is a big U.K. booster. And he's been talking up some new pluses for the biopharma industry, including a lower tax rate on IP-generated profits. Witty, though, also believes that the country needs more venture funds in order for the industry to compete with some up-and-coming European countries. Story
> The FDA has provided priority review status for Exelixis's ($EXEL) cabozantinib for thyroid cancer. Story
> University of Alabama spinout Vaxin has moved to Maryland, joining a cluster of vaccine developers near Washington, D.C. Story
Pharma News
@FiercePharma: Endocyte poaches Novartis exec David Meek to be its chief commercial officer. Report | Follow @FiercePharma
> Shire CEO sees consumer-goods strategies in pharma's future. More
> Pay-for-delay deals could be upended by the Supreme Court. Article
@FierceMedDev: Another day, another Covidien 510(k) clearance, this time for a new bedside monitoring system. Report | Follow @FierceMedDev
@MarkHFierce: Four years of working with FDA pays off. Proteus gained clearance for a new ingestible sensor. Release | Follow @MarkHFierce
@DamianFierce: A new pig-flesh-based implant could make certain knee surgeries more successful. More | Follow @DamianFierce
> Roper buys Dx firm Sunquest for $1.4B. News
> Devicemaker Kai Medical to merge with biotech Novogen. More
> Covidien rolls out updated patient monitoring system in U.S. Story
Biotech IT News
> AZ's R&D information chief eyes improved trial success. Story
> Models shed light on cocaine-curbing enzymes. More
> Illumina seeks cut of bioinformatics biz with cloud system. Article
> AstraZeneca taps Amazon-like service for outsourcing research. News
> Complete Genomics, Ingenuity combine forces to understand genomes. Report
CRO News
> Beta Pharma to manufacture Sunshine's targeted cancer drug. Story
> Quintiles inks deal to promote COPD drug in U.K. Article
> Analysts: CMO market will double by 2018. News
> 438 died in Indian clinical trials last year. Report
> Covance takes a $12.7M loss in Q2. News
And Finally… Investigators say that curcurmin, an ingredient in curry spice which acts as an anti-inflammatory compound, can help prevent diabetes. Story